Met Test LLC is a leading provider of cardiopulmonary diagnostic services, specializing in cardiorespiratory fitness assessment and heart disease prevention. With over 20 years of expertise and a database of over 15.5 million patients, they offer individual-specific management feedback using state-of-the-art technology and proprietary pattern recognition software. Their services help at-risk organizations optimize the cardiovascular health of their population, reducing healthcare costs and promoting a healthy workforce.
Met Test LLC's cardiopulmonary exercise test (CPET) is the gold standard for assessing cardiorespiratory fitness and detecting cardiac dysfunction caused by ischemic heart disease. This non-invasive test, ordered by doctors, provides detailed reports on heart and lung health, enabling the creation of custom treatment plans. By tracking patients' response to therapy and implementing lifestyle changes, exercise prescriptions, and medical management, Met Test LLC aims to improve longevity and reduce the risk of cardiovascular diseases.
Generated from the website